Here’s Why Neoleukin Therapeutics Dropped Today – The Motley Fool
Here’s Why Neoleukin Therapeutics Dropped Today The Motley Fool … Continue reading →
Here’s Why Neoleukin Therapeutics Dropped Today – The Motley Fool Read More »
Common Stock Warrants
Appian Announces Financing Support for Harte Gold Corp. – Canada NewsWire
Appian Announces Financing Support for Harte Gold Corp. Canada NewsWire … Continue reading →
Appian Announces Financing Support for Harte Gold Corp. – Canada NewsWire Read More »
Appian Announces Financing Support for Harte Gold Corp. – Benzinga
Appian Announces Financing Support for Harte Gold Corp. Benzinga … Continue reading →
Appian Announces Financing Support for Harte Gold Corp. – Benzinga Read More »
Datable Technology Corporation $1,000,000 Non-Brokered Private Placement – Canada NewsWire
Datable Technology Corporation $1,000,000 Non-Brokered Private Placement Canada NewsWire … Continue reading →
Datable Technology Corporation $1,000,000 Non-Brokered Private Placement – Benzinga
Datable Technology Corporation $1,000,000 Non-Brokered Private Placement Benzinga … Continue reading →
Datable Technology Corporation $1,000,000 Non-Brokered Private Placement – Benzinga Read More »
Replimune Group’s $115 Million Registered Equity Offering – Global Legal Chronicle – Global Legal Chronicle
Replimune Group’s $115 Million Registered Equity Offering – Global Legal Chronicle Global Legal Chronicle … Continue reading →
TRANS-LUX CORPORATION (OTCMKTS:TNLX) Files An 8-K Entry into a Material Definitive Agreement – Market Exclusive
TRANS-LUX CORPORATION (OTCMKTS:TNLX) Files An 8-K Entry into a Material Definitive Agreement Market Exclusive … Continue reading →
TSX Venture Exchange Stock Maintenance Bulletins – Canada NewsWire
TSX Venture Exchange Stock Maintenance Bulletins Canada NewsWire … Continue reading →
TSX Venture Exchange Stock Maintenance Bulletins – Canada NewsWire Read More »
TSX Venture Exchange Stock Maintenance Bulletins – Benzinga
TSX Venture Exchange Stock Maintenance Bulletins Benzinga … Continue reading →
TSX Venture Exchange Stock Maintenance Bulletins – Benzinga Read More »
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts – Benzinga
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts Benzinga … Continue reading →